1-5 of 5
Alison T. Stopeck
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Sulindac, a Nonselective NSAID, Reduces Breast Density in Postmenopausal Women with Breast Cancer Treated with Aromatase Inhibitors

Patricia A. Thompson, Chuan Huang, Jie Yang, Betsy C. Wertheim, Denise Roe, Xiaoyue Zhang, Jie Ding, Pavani Chalasani, Christina Preece, Jessica Martinez, H.-H. Sherry Chow, Alison T. Stopeck
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (20): 5660–5668.
https://doi.org/10.1158/1078-0432.CCR-21-0732
Published: 15 October 2021
View article titled, Sulindac, a Nonselective NSAID, Reduces Breast Density in Postmenopausal Women with Breast Cancer Treated with Aromatase Inhibitors
Open the PDF for Sulindac, a Nonselective NSAID, Reduces Breast Density in Postmenopausal Women with Breast Cancer Treated with Aromatase Inhibitors in another window
Includes: Supplementary data
Journal Articles

Changes in Bone Turnover Marker Levels and Clinical Outcomes in Patients with Advanced Cancer and Bone Metastases Treated with Bone Antiresorptive Agents

Allan Lipton, Matthew R. Smith, Karim Fizazi, Alison T. Stopeck, David Henry, Janet E. Brown, Neal D. Shore, Fred Saad, Andrew Spencer, Li Zhu, Douglas J. Warner
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2016) 22 (23): 5713–5721.
https://doi.org/10.1158/1078-0432.CCR-15-3086
Published: 30 November 2016
View article titled, Changes in Bone Turnover Marker Levels and Clinical Outcomes in Patients with Advanced Cancer and Bone Metastases Treated with Bone Antiresorptive Agents
Open the PDF for Changes in Bone Turnover Marker Levels and Clinical Outcomes in Patients with Advanced Cancer and Bone Metastases Treated with Bone Antiresorptive Agents in another window
Includes: Supplementary data
Journal Articles

Phase I Safety and Pharmacokinetic Study of Bavituximab, a Chimeric Phosphatidylserine-Targeting Monoclonal Antibody, in Patients with Advanced Solid Tumors

David E. Gerber, Alison T. Stopeck, Lucas Wong, Lee S. Rosen, Philip E. Thorpe, Joseph S. Shan, Nuhad K. Ibrahim
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (21): 6888–6896.
https://doi.org/10.1158/1078-0432.CCR-11-1074
Published: 31 October 2011
View article titled, Phase I Safety and Pharmacokinetic Study of Bavituximab, a Chimeric Phosphatidylserine-Targeting Monoclonal Antibody, in Patients with Advanced Solid Tumors
Open the PDF for Phase I Safety and Pharmacokinetic Study of Bavituximab, a Chimeric Phosphatidylserine-Targeting Monoclonal Antibody, in Patients with Advanced Solid Tumors in another window
Journal Articles

Phase II Study of Direct Intralesional Gene Transfer of Allovectin-7, an HLA-B7/β2-Microglobulin DNA-Liposome Complex, in Patients with Metastatic Melanoma

Alison T. Stopeck, Amanda Jones, Evan M. Hersh, John A. Thompson, Deborah M. Finucane, John C. Gutheil, Rene Gonzalez
Journal: Clinical Cancer Research
Clin Cancer Res (2001) 7 (8): 2285–2291.
Published: 01 August 2001
View article titled, Phase II Study of Direct Intralesional Gene Transfer of Allovectin-7, an HLA-B7/β2-Microglobulin DNA-Liposome Complex, in Patients with Metastatic Melanoma
Open the PDF for Phase II Study of Direct Intralesional Gene Transfer of Allovectin-7, an HLA-B7/β2-Microglobulin DNA-Liposome Complex, in Patients with Metastatic Melanoma in another window
Journal Articles

Loss of B7.2 (CD86) and Intracellular Adhesion Molecule 1 (CD54) Expression Is Associated with Decreased Tumor-infiltrating T Lymphocytes in Diffuse B-cell Large-cell Lymphoma

Alison T. Stopeck, Andrea Gessner, Thomas P. Miller, Evan M. Hersh, Cynthia S. Johnson, Haiyan Cui, Yvette Frutiger, Thomas M. Grogan
Journal: Clinical Cancer Research
Clin Cancer Res (2000) 6 (10): 3904–3909.
Published: 01 October 2000
View article titled, Loss of B7.2 (CD86) and Intracellular Adhesion Molecule 1 (CD54) Expression Is Associated with Decreased Tumor-infiltrating T Lymphocytes in Diffuse B-cell Large-cell Lymphoma
Open the PDF for Loss of B7.2 (CD86) and Intracellular Adhesion Molecule 1 (CD54) Expression Is Associated with Decreased Tumor-infiltrating T Lymphocytes in Diffuse B-cell Large-cell Lymphoma in another window